Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Can Polestar Psnyw Stock Rebound In 2026 Price At 3.99 Up 1.27 20260406 Is Smurfit Sw Stock Overvalued Now Price At 41.77 Down 0.70 20260413 Is Troops Troo Stock Cheap Compared To Earnings Price At 2.42 Up 2.98 20260413 Oil Price Plunge and SP 500 Record High Bitcoins Correlation Dynamics in Focus China Signals Openness to TikTok Deal ByteDance Founder Met Elon Musk Fed Rate Cut Prospects Dim as Jobs Data Signals Sticky Inflation China Signals Openness to Deal That Could Keep TikTok Operating in the US CD Rates Reach Up to 4 APY as Savings Yields Remain Attractive UKGulf Trade Deal Hailed as Monumental Achievement by Bahrain Minister Mattel Q1 2026 Earnings Narrower Than Expected Loss as EPS Beats Estimates COLD Q1 2026 Earnings EPS Surprises to the Upside as Loss Narrows Core Scientific Q1 2026 Earnings Massive EPS Miss Amid Cryptocurrency Mining Headwinds Stock Edges Higher Saratoga Investment Corp SAT Q1 2026 Earnings Steep EPS Miss Amid Challenging Investment Environment Standard Motor Products SMP Q1 2026 Earnings EPS Surpasses Estimates by 678 Despite Unreported Revenue Castle Biosciences Inc CSTL Q1 2026 Earnings NarrowerThanExpected Loss Drives Modest Optimism Ecolab ECL Surges 4 Breaking Through Key Resistance Levels Clean Energy Technologies Inc CETY Nears Support as Shares Decline 373 Seven Hills Realty Trust SEVN Gains 167 as Realty Sector Shows Resilience Peoples Bancorp PEBO Edges Higher as Stock Holds Above Support at 33 Bicara Therapeutics BCAX Surges 4 on Renewed Buying Interest Resistance Level in Sight PFIS Q1 2026 Earnings EPS Misses Estimates Despite Positive Market Reaction PMTV Q1 2026 Earnings Significant EPS Miss Amidst Elevated Mortgage Rates PAGP Q1 2026 Earnings Stunning EPS Beat Drives Stock Higher Trevi Therapeutics Q1 2026 Earnings Narrowing Losses but Trial Failures Weigh on Sentiment Immatics NV IMTX Q1 2026 Earnings WiderThanExpected Loss Amid Clinical Progress CTAS Q1 2026 Earnings EPS Slightly Misses Estimates Despite Positive Stock Reaction